Best drug tests for workplace screening

The 10-panel dip card is the workhorse format for high-volume employer screening, and the format wins on the same axes it always has: lowest per-test cost in the 10-panel family, compact storage and shipping, and the flexibility to run multiple cards from a single collection cup if your policy requires a specialty add-on. For a hiring desk running 50+ pre-employment screens a week, the per-test cost savings over an integrated cup add up to meaningful annual dollars.

The panel scope is set up specifically for employer policy testing. The DOT-5 analytes (THC, COC, OPI, AMP, PCP) are present at SAMHSA-aligned cutoffs, and the five additional analytes (benzodiazepines, barbiturates, methadone, MDMA, oxycodone) cover the most common policy expansions employers make beyond the DOT minimum. If your policy includes something else — fentanyl, buprenorphine, ETg — pair this with a strip or step up to our 12- or 14-panel cup.

For programs whose collection workflow is built around experienced collectors who read the device immediately after the donor's specimen is transferred, the dip card is faster end-to-end than an integrated cup and costs less per test. For programs where collection and read may be separated by interruptions or where collectors are less experienced, our integrated cup formats absorb workflow variation better.

The 12-panel clicker is our pick when the workflow benefits from collector-controlled read timing. The clicker mechanism keeps the test strips dry until the collector activates the device, so the five-minute read window starts when the collector is ready — not at the moment the donor voids. For HR offices that sometimes batch multiple pre-employment donors in a morning, urgent-care employer screening, and any workflow where the collector may be interrupted between collection and read, the clicker absorbs that variation and produces cleaner reads.

The broader panel adds analytes most employer policies care about — buprenorphine coverage matters in markets with high MAT prevalence in the labor pool — and the integrated cup form factor gives you one sealed vessel for chain of custody, which is the simpler story to defend if a positive result is ever contested in an HR proceeding or unemployment hearing.

This is the right SKU when your employer policy testing scope is a common workplace 5-panel — amphetamines, cocaine, methamphetamine, opiates, and marijuana — which substitutes methamphetamine for PCP relative to the federal SAMHSA-5. Methamphetamine prevalence in the working-age population today is substantially higher than PCP prevalence, so many employer policies that update from the legacy federal 5-panel land here.

Important scope note: this is not the SAMHSA-5 / DOT-5 panel. The federal SAMHSA-5 panel screened under 49 CFR Part 40 specifically requires phencyclidine (PCP), and this SKU does not include PCP. If your employer policy explicitly requires SAMHSA-5 alignment, step up to the 10- or 12-panel SKU (which includes PCP) or contact us about a PCP-inclusive 5-panel.

Our recommendation for most employer programs in 2026 is to step up to the 10- or 12-panel scope — most modern policies test beyond five analytes, and the per-test cost gap is small relative to the value of catching benzodiazepine and oxycodone misuse, which is meaningfully present in the working-age population today.

Confirm BioSciences is an established manufacturer in the workplace drug-testing market. The DrugConfirm Advanced cup line sits in the same FDA-cleared, CLIA-waived category as the other major manufacturers' point-of-care immunoassay devices.

Many industry buyers report that whether this brand is the right pick depends less on the device itself and more on which channel you order through, since procurement terms can differ between direct and reseller orders. If you are evaluating this brand against ours, get a real quote at your annual volume from both — published per-unit numbers are rarely what you actually pay at your volume tier. Verify current product specifications, certifications, and pricing directly with the manufacturer.

Premier Biotech publishes both a urine cup line (CupTox) and oral-fluid devices on their site. CupTox sits in the same point-of-care immunoassay category as the other major manufacturers' urine cups.

The matrix-consolidation angle is the main reason an employer might choose Premier specifically for urine cups — if you already run an oral-fluid product for reasonable-suspicion testing and want one vendor and one invoice across matrices. For urine-only employer programs, the case for switching specifically to CupTox over a vendor focused on the urine market is weaker; evaluation comes down to per-unit cost at your volume, lead time, and B2B procurement terms. Verify current product specifications and certifications directly with the manufacturer.

Phamatech's publicly available materials indicate the company offers both a device-manufacturing line and laboratory services. For employer programs without an established MRO or lab relationship, the single-vendor workflow can simplify account management and invoicing. For programs that already have an MRO and a lab in place, the bundle is less of a differentiator, and AccuTest evaluates on its own as a point-of-care device in the same FDA-cleared, CLIA-waived category as the other major manufacturers.

If you are evaluating this brand against ours, the meaningful comparison is per-unit cost at your annual volume, lead time on stocked SKUs, and the procurement experience. Verify current product specifications, certifications, lab status, and pricing directly with the manufacturer.